Bruce SF, Wu S, Ribeiro JR, Farrell A, et al. HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis. Gynecol Oncol 2023;172:98-105.
PMID: 37003074